ENDRA Life Sciences

NDRANasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$9.344 M

$6.23 -1.27%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$7.03M

Loss-making

Shares outstanding

1,499,838

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#23iTonicITOC$37.5M
#24IridexIRIX$11.2M
#25ENDRA Life SciencesNDRA$9.34M
#26Nexalin TechnologyNXL$3.84M
#27Valion BioVBIO$3.20M

What if ENDRA Life Sciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$20,158,156

Per share 3,235,659× higher

Bitcoin $1.74T

$1,161,229

Per share 186,393× higher

Nvidia $5.52T

$3,677,575

Per share 590,301× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for ENDRA Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.